Prospective Follow-up of Patients With Glycogen Storage Disease Type III - Trial NCT01563705
Access comprehensive clinical trial information for NCT01563705 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut de Myologie, France and is currently status unknown. The study focuses on Neuromuscular Disorders. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Institut de Myologie, France
Timeline & Enrollment
N/A
Feb 01, 2011
Aug 01, 2016
Primary Outcome
Knee flexion and extension strength,Knee flexion and extension strength,Knee flexion and extension strength,Time to perform each motor function test,Time to perform each motor function test,Time to perform each motor function test,Gait speed measured during the 6 minutes walk test,Gait speed measured during the 6 minutes walk test,Gait speed measured during the 6 minutes walk test
Summary
The aim of this study is to improve knowledge of natural history and methods of monitoring
 the evolution of Glycogen storage disease type III regarding the muscle and to study the
 prospective approach of large series of patients, and using the same protocol for the follow
 up of the children and adults.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01563705
Non-Device Trial